We provide you with 20 years of free, institutional-grade data for PBYI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PBYI. Explore the full financial landscape of PBYI stock.
| Reported Date | CIK | Ticker | Type |
|---|
Puma Biotechnology, Inc(NASDAQ:PBYI) 
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the adjuvant treatment of adult patients with early st...
Website: http://www.pumabiotechnology.com
Founded: 2007
Full Time Employees: 269
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about PBYI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.